Exosomal immune decoy integrates cfDNA scavenging and mTOR inhibition for synergistic lupus nephritis therapy
Theranostics · 2026
DOI: 10.7150/thno.130906 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2026. Verfasst von Mingxin Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Lupus Nephritis, TOR Serine-Threonine Kinases, Exosomes, Sirolimus. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
- Department of Rheumatology and Immunology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
- Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
Zitieren
APA
Zhu, M., Xu, Q., Tang, Z., Wang, Z., Zhu, H., & Sun, L. (2026). Exosomal immune decoy integrates cfDNA scavenging and mTOR inhibition for synergistic lupus nephritis therapy. Theranostics. https://doi.org/10.7150/thno.130906
Vancouver
Zhu M, Xu Q, Tang Z, Wang Z, Zhu H, Sun L. Exosomal immune decoy integrates cfDNA scavenging and mTOR inhibition for synergistic lupus nephritis therapy. Theranostics. 2026. doi:10.7150/thno.130906
BibTeX
@article{Zhu2026,
author = {Zhu, Mingxin and Xu, Qinyao and Tang, Zhicheng and Wang, Zexin and Zhu, Haofang and Sun, Lingyun},
title = {Exosomal immune decoy integrates cfDNA scavenging and mTOR inhibition for synergistic lupus nephritis therapy},
journal = {Theranostics},
year = {2026},
doi = {10.7150/thno.130906}
}
EUVIMED